The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20050073: Worley Group Limited; Parsons Employee Stock Ownership Plan
20050039: J. W. Childs Equity Partners, III, L.P.; Vestar Capital Partners, III, L.P.
20050020: PacifiCare Health Systems, Inc.; American Medical Security Group, Inc.
20050087: ViroPharma Incorporated; Eli Lilly and Company
20050069: AFFC Holdings, Inc.; BP p.l.c.
Appliance Labeling Rule - Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
First American Payment Processing, Inc.; et al.
20050117: Estate of Ernest L. Samuel; Mr. Charles E. Pompea
20050108: Computer Associates International, Inc.; Netegrity, Inc.
20050102: Computershare Limited; DST Systems, Inc.
20050094: Wellspring Capital Partners III, LLP; The Stanley Works
20050081: William Sauder; Riverside Forest Products Limited
20050051: Cooper Cameron Corporation; Precision Castparts Corp.
20050050: Henkel KGaA; The Clorox Company
Sanofi-Synthelabo and Aventis, In the Matter of
The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.